Targeted Mass Spectrometry Assays for Diabetes and Obesity Research (TaMADOR)

The 2024 TaMADOR Symposium will be held on May 6th from 8am to 4pm at UW Medicine, South Lake Union (Brotman Auditorium, D Building, 850 Republican St, Seattle, WA).

Topics include:

  • The TaMADOR Consortium: Interlaboratory Transfer of a Combined Antibody-free Insulin/C-peptide Assay
  • Preparing for the Interlaboratory Transfer of a Novel Assay to Measure Glucagon and Oxyntomodulin
  • LC-MS Assays for Specific Prohormone Proteoforms (Insulin and IAPP) Relevant to Type 1 Diabetes
  • Progress Toward a Proteolysis-peptide Immunoaffinity Enrichment-LC-MS/MS Assay for Proinsulin
  • Hemoglobin A1c as a Clinical Biomarker
  • LC-MS Assays for Obesity Biomarkers
  • Using Mass Spectrometry for Monitoring Patient Response to Therapy

Register for the symposium